AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012
Nov 9, 2012
30583_dirs_2012-11-09_c4b9fb0b-1f8a-4357-b6ab-9d6a84ebb978.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-11-07
Reporting Person: LEWIS ALAN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-07 | Common Stock | M | 15000 | $17.33 | Acquired | 30900 | Direct |
| 2012-11-07 | Common Stock | S | 15000 | $46.80 | Disposed | 15900 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-11-07 | Stock Option (right to buy) Common Stock | $17.33 | M | 15000 | Disposed | 2017-06-07 | Common Stock (15000) | Direct |
Footnotes
F1: Options vest 1/4th each on September 7, 2007, December 7, 2007, March 7, 2008 and June 7, 2008.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19